AMGN vs DAVE Stock Comparison
Compare AMGN and DAVE across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between AMGN and DAVE?
DAVE leads the current stock comparison as Dave Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Amgen Inc. vs Dave Inc.
DAVE leads
DAVE leads by 15 AIQ points, primarily on Momentum and Quality, having only recently taken the lead back from AMGN.
Competitive: 4 of 6 evidence groups support DAVE, the lead recently changed hands, and its signal state is cleanly positive.
The Algovestiq AIQ Score currently favors DAVE over AMGN, 59 versus 44 as of Sep 11, 2026. DAVE's advantage is driven primarily by stronger momentum and quality, while AMGN holds the stronger risk resilience profile. DAVE also shows the weaker technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor DAVE today, and the comparison is rated Competitive on stability: the lead has already changed hands inside the comparison window. DAVE lead: Reversed — AMGN led by 11 AIQ points 30 sessions ago; DAVE now leads by 15.
Compare Amgen Inc. and Dave Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare AMGN and DAVE against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum15 vs 59DAVE +44
- Quality70 vs 81DAVE +11
- Value44 vs 52DAVE +8
- Risk Resilience39 vs 31AMGN +8
4 of 6 evidence groups favor DAVE. DAVE’s edge is concentrated in momentum and quality; AMGN keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.
No factor moved materially.
No new signals fired.
Largest factor move: Momentum -2
No new signals fired.
DAVE's lead narrowed by 1 AIQ points in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — AMGN and DAVE both carry a full feed there.
The central trade-off
DAVE (Dave Inc.): the stronger current systematic profile, led by momentum and quality.
AMGN (Amgen Inc.): the counter-case, on risk resilience, fundamentals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
DAVEDAVE on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
AMGNAMGN on combined revenue and EPS growth.
Value
DAVEDAVE on the peer-relative Value factor, by 8 points.
Momentum
DAVEDAVE on the Momentum factor, by 44 points.
Lower downside
AMGNAMGN on Risk Resilience, by 8 points.
Analyst upside
DAVEDAVE on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | AMGN | DAVE | Note |
|---|---|---|---|
| Implied upside to target | -0.2% | +13.1% | DAVE has more room |
| Target dispersion | +61.1% | +44.1% | Lower is tighter analyst agreement |
| Consensus | Hold | Buy | Context, not a primary driver |
| Analysts covering | 18 | 7 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor DAVE. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | DAVE | 44 vs 59 |
| Fundamentals | AMGNon balance | revenue growth 16.7% vs 7.8%; EPS growth 30.6% vs -87.7%; TTM ROE 89.3% vs 84.4%; gross margin 72.7% vs 83.3%; operating margin 33.2% vs 34.5% — AMGN takes 3 of 5 decided legs, not all of them |
| Valuation | DAVE | Value 44 vs 52 |
| Technicals | DAVE | Price vs 50-day -5.4% vs -7.3%; vs 200-day 6.5% vs 36.5% |
| Risk Resilience | AMGN | Risk Resilience 39 vs 31 |
| Analyst expectations | DAVE | Target upside -0.2% vs 13.1% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AMGN and DAVE and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 15 points. (supports the conclusion holding)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The lead has swung materially session to session. (argues the conclusion is provisional)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on DAVE.
How the comparison changed
119 daily snapshots · May 4 – Sep 10DAVE lead: Reversed — AMGN led by 11 AIQ points 30 sessions ago; DAVE now leads by 15.
- Today
- DAVE +15
- 44 vs 59
- 7 sessions ago
- DAVE +8
- 58 vs 66
- 30 sessions ago
- AMGN +11
- 63 vs 52
- 90 sessions ago
- DAVE +9
- 61 vs 70
The lead changed hands 4 times in this window, most recently on Aug 26 when DAVE moved ahead of AMGN.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
4 bullish / 2 bearish, conflicted
- Golden Cross Active — bullish, trend, long horizon (11.03%)
- BB Lower Band Breach — bullish, volatility, short horizon
- Keltner Channel Breakdown — bearish, volatility, short horizon
3 bullish / 0 bearish / 1 neutral
- Golden Cross Active — bullish, trend, long horizon (44.11%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (6.06%)
AMGN is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.34%, AIQ 0 points).
Price and the AIQ Score both moved down over the latest session (price -2.13%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1AMGN closes the Momentum gap — currently 44 points behind, the largest single contributor to DAVE's edge.
- 2AMGN's Keltner Channel Breakdown resolves — a bearish volatility rule currently active against it.
- 3DAVE's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
AMGN leads on balance| Metric | AMGN | DAVE |
|---|---|---|
| Revenue growth (YoY) | 16.7% | 7.8% |
| EPS growth (YoY) | 30.6% | -87.7% |
| Gross margin | 72.7% | 83.3% |
| Operating margin | 33.2% | 34.5% |
| Return on equity (TTM) | 89.3% | 84.4% |
| Debt to equity | 4.9 | 1.29 |
Performance
DAVE leads 6 of 6 windows| Metric | AMGN | DAVE |
|---|---|---|
| 1 week (5 sessions) | -8.5% | -3.9% |
| 1 month (20 sessions) | -8.1% | 13.3% |
| 3 months (63 sessions) | 13.2% | 32.3% |
| 6 months (126 sessions) | 1.3% | 60.5% |
| Year to date | 16.9% | 61.9% |
| 1 year (252 sessions) | 36.5% | 83.6% |
Technicals
DAVE has the stronger structure| Metric | AMGN | DAVE |
|---|---|---|
| RSI (14) | 24.4 | 56.7 |
| ADX (14) | 40 | 11.6 |
| Price vs 50-day | -5.4% | -7.3% |
| Price vs 200-day | 6.5% | 36.5% |
| Volatility (1M, annualized) | 40.9% | 65.4% |
Risk
AMGN is the more resilient| Metric | AMGN | DAVE |
|---|---|---|
| Beta | 0.54 | 2.52 |
| Sharpe ratio | 1.07 | 1.01 |
| Sortino ratio | 1.64 | 1.53 |
| Max drawdown | -16.6% | -37.9% |
| Current drawdown | -13.9% | -19% |
| Annualized volatility | 29.6% | 70% |
| Value at risk (95%) | -2.5% | -6.6% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AMGN or DAVE?
On the Algovestiq AIQ Score, DAVE is the stronger of the two as of Sep 11, 2026, scoring 59 against AMGN's 44. The edge comes from momentum and quality. AMGN is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AMGN or DAVE the better buy right now?
DAVE carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor DAVE over AMGN?
The composite weights Quality, Value, Momentum and Risk Resilience. DAVE leads Momentum by 44 points; DAVE leads Quality by 11 points; DAVE leads Value by 8 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AMGN or DAVE?
Analyst price targets imply -0.2% upside for AMGN and +13.1% for DAVE, so the Street currently favors DAVE. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AMGN or DAVE?
DAVE is the better-valued of the two on the peer-relative Value factor. DAVE on the peer-relative Value factor, by 8 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AMGN or DAVE?
AMGN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AMGN or DAVE?
DAVE on the Momentum factor, by 44 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AMGN or DAVE?
AMGN is the more resilient of the two, so the other name carries the higher downside risk. AMGN on Risk Resilience, by 8 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AMGN more profitable than DAVE?
The profitability evidence is mixed: gross margin 72.7% vs 83.3%; operating margin 33.2% vs 34.5%; ttm roe 89.3% vs 84.4%. AMGN leads on one measure and DAVE on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is DAVE's lead over AMGN getting stronger or weaker?
DAVE lead: Reversed — AMGN led by 11 AIQ points 30 sessions ago; DAVE now leads by 15. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has changed hands 4 times in that window, most recently on 2026-08-26, when DAVE moved ahead of AMGN.
What would change the AMGN vs DAVE verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AMGN closes the Momentum gap — currently 44 points behind, the largest single contributor to DAVE's edge; AMGN's Keltner Channel Breakdown resolves — a bearish volatility rule currently active against it; DAVE's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about AMGN and DAVE?
AMGN: 4 bullish / 2 bearish, conflicted. DAVE: 3 bullish / 0 bearish / 1 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AMGN is Golden Cross Active (bullish, long horizon). On DAVE it is Golden Cross Active (bullish, long horizon).
Compare AMGN and DAVE with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.